These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6994991)

  • 1. Determining the probability of an important difference in bioavailability.
    Rodda BE; Davis RL
    Clin Pharmacol Ther; 1980 Aug; 28(2):247-52. PubMed ID: 6994991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting potential safety issues in clinical trials by Bayesian screening.
    Gould AL
    Biom J; 2008 Oct; 50(5):837-51. PubMed ID: 18932142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar.
    Schall R
    Biometrics; 1995 Jun; 51(2):615-26. PubMed ID: 7662849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance not statistical significance: a simple Bayesian alternative to p values.
    Burton PR; Gurrin LC; Campbell MJ
    J Epidemiol Community Health; 1998 May; 52(5):318-23. PubMed ID: 9764283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring clinical trials based on predictive probability of significance.
    Choi SC; Pepple PA
    Biometrics; 1989 Mar; 45(1):317-23. PubMed ID: 2720057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Clinical Trial Results to Clinical Practice.
    Zarbin MA; Bhagat N; Mukkamala LK
    Dev Ophthalmol; 2017; 60():175-189. PubMed ID: 28427076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical aspects of comparative bioavailability trials.
    Westlake WJ
    Biometrics; 1979 Mar; 35(1):273-80. PubMed ID: 583027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.
    Schuirmann DJ
    J Pharmacokinet Biopharm; 1987 Dec; 15(6):657-80. PubMed ID: 3450848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical Bayes estimates of subgroup effects in clinical trials.
    Davis CE; Leffingwell DP
    Control Clin Trials; 1990 Feb; 11(1):37-42. PubMed ID: 2157579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical significance and clinical relevance: the importance of power in clinical trials in dermatology.
    Bhardwaj SS; Camacho F; Derrow A; Fleischer AB; Feldman SR
    Arch Dermatol; 2004 Dec; 140(12):1520-3. PubMed ID: 15611433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian approach to bioequivalence for the 2 x 2 changeover design.
    Selwyn MR; Dempster AP; Hall NR
    Biometrics; 1981 Mar; 37(1):11-21. PubMed ID: 7018605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes.
    Brophy JM; Joseph L
    JAMA; 1995 Mar; 273(11):871-5. PubMed ID: 7869558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Null Hypotheses, Interval Estimation, and Bayesian Analysis.
    Shin JJ; Zurakowski D
    Otolaryngol Head Neck Surg; 2017 Dec; 157(6):919-920. PubMed ID: 29192854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Types of bioequivalence and related statistical considerations.
    Hauck WW; Anderson S
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential clinical trials for normal variates using interval composite hypotheses.
    Lachin JM
    Biometrics; 1981 Mar; 37(1):87-101. PubMed ID: 7248445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse-Bayes analysis of two common misinterpretations of significance tests.
    Held L
    Clin Trials; 2013 Apr; 10(2):236-42. PubMed ID: 23329516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new PK equivalence test for a bridging study.
    Novick SJ; Zhang X; Yang H
    J Biopharm Stat; 2016; 26(5):992-1002. PubMed ID: 26882145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials and statistical verdicts: probable grounds for appeal.
    Diamond GA; Forrester JS
    Ann Intern Med; 1983 Mar; 98(3):385-94. PubMed ID: 6830080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical significance--a misconstrued notion in medical research.
    Nurminen M
    Scand J Work Environ Health; 1997 Jun; 23(3):232-5. PubMed ID: 9243735
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.